- Oct 20-23, 2019
American Conference on Pharmacometrics, Orlando, FL
ISB presents poster on "UNDERSTANDING CLINICAL OUTCOME OF ADUCANUMAB TRIALS IN ALZHEIMER USING A QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL"
- Oct 31-Nov 3, 2019
CNS Summit, Boca Raton, FL
On invitation, ISB presents "QUANTITATIVE SYSTEMS PHARMACOLOGY AS A HUMAN AUGMENTED INTELLIGENCE TOOL FOR CNS R&D"
- Dec 4-Dec 7, 2019
Clinical Trials in Alzheimer's Disease Meeting in San Diego, CA
ISB co-organizes a symposium on "NEW PREDICTIVE PLATFORMS FOR ADVANCING DRUG COMBINATION APPROACHES FOR ALZHEIMER PATHOLOGY"
Program: Prof Lon Schneider (UCSF) chairs a session with Richard Kennedy (Univ of Alabama) on "In Silico Screening of Medications for Slowing Alzheimer's Disease Progression in a Clinical Trials Meta-database", Tom Anastasiou (Univ of Illinois) on "Drug Combination Identification through Correlation between a Clinical Dataset and a Computational Model " and Hugo Geerts (In Silico Biosciences) on "Evaluating pharmacodynamic interactions in drug combinations using Quantitative Systems Pharmacology analysis of clinical trials".
- Feb 19-Feb 21, 2020
International Society for CNS Trial Methodologies, Washington, DC
ISB will be participating in a panel discussion on "Artificial Intellegience and Machine Learning in CNS Clinical Trials"
For a list of past events, please see ISB News.